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Abstract:  47 
The ratio of the length of the index finger to that of the ring finger (2D:4D) is sexually dimorphic and 48 
is commonly used as a noninvasive biomarker of prenatal androgen exposure. Most association 49 
studies of 2D:4D ratio with a diverse range of sex-specific traits have typically involved small sample 50 
sizes and have been difficult to replicate, raising questions around the utility and precise meaning of 51 
the measure. In the largest genome-wide association meta-analysis of 2D:4D ratio to date (N=15,661, 52 
with replication N=75,821), we identified eleven loci (nine novel) explaining 3.8% of the variance in 53 
mean 2D:4D ratio. We also found weak evidence for association (β=0.06; P=0.02) between 2D:4D ratio 54 
and sensitivity to testosterone (length of the CAG microsatellite repeat in the androgen receptor gene) 55 
in females only. Furthermore, genetic variants associated with (adult) testosterone levels and/or sex 56 
hormone-binding globulin were not associated with 2D:4D ratio in our sample. Although we were 57 
unable to find strong evidence from our genetic study to support the hypothesis that 2D:4D ratio is a 58 
direct biomarker of prenatal exposure to androgens in healthy individuals, our findings do not 59 
explicitly exclude this possibility, and pathways involving testosterone may become apparent as the 60 
size of the discovery sample increases further. Our findings provide new insight into the underlying 61 
biology shaping 2D:4D variation in the general population. 62 
  63 
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Introduction: 64 
It has long been hypothesized that prenatal sex steroids, particularly testosterone, permanently 65 
modify the developing nervous system during critical periods of development, which in turn influences 66 
behavior in later life(1). Whilst animal models have largely supported this “Organizational 67 
hypothesis”(2), evidence from human studies has been much more limited, as accurately measuring 68 
prenatal testosterone exposure is extremely difficult. Based on several lines of indirect evidence, it 69 
has widely been hypothesized that the ratio of the length of the index finger to the length of the ring 70 
finger (2D:4D) is a marker of prenatal androgen exposure(3) and could therefore be used as a 71 
retrospective non-invasive biomarker of prenatal testosterone exposure. Males are believed to have 72 
greater prenatal testosterone exposure than females, and this is thought to determine the 73 
consistently observed lower ratio of the first (index) finger to the third (ring) finger in males (4, 5). This 74 
sex difference is relatively stable over time(3, 6, 7), and although there is variation in 2D:4D ratio 75 
across ethnic groups(8, 9), sexual dimorphism in the digit ratio is consistent across ethnicities(10). 76 
Based on the assumption that the digit ratio is a marker of prenatal testosterone exposure, 77 
associations have been reported between 2D:4D ratio and a broad range of sex-dependent behaviors 78 
and diseases including academic(11) and sporting performance(12, 13), social behaviors(14-16), 79 
fertility(17, 18), Alzheimer’s disease(19), metabolic syndrome indices(20) and autism spectrum 80 
disorder(21). Despite the extensive literature regarding 2D:4D ratio(22), most published studies have 81 
used small sample sizes (often fewer than 100 individuals) and have been difficult to replicate, raising 82 
questions around the utility and precise meaning of the measure(23). 83 
 84 
Several twin studies have indicated that 2D:4D ratio is highly heritable (h2: 50-80%)(24-28). Two 85 
relatively small genome-wide association studies (GWAS) of 2D:4D ratio have reported two loci 86 
influencing variation in the trait(29, 30). The minor allele (A) at rs314277 in LIN28B was associated 87 
with increased 2D:4D ratio, delayed menarche in females(31) and increased height(32). The minor 88 
allele (T) at the second locus, rs4902759 in SMOC1, was associated with decreased 2D:4D ratio. 89 
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Pedigree studies have shown that mutations in SMOC1 are associated with Waardenburg 90 
anophthalmia (OMIM 206920), a syndrome that commonly includes abnormal digits(33-35). 91 
Additionally, the protein encoded by SMOC1 has been shown to be up-regulated by androgens(36, 37) 92 
and down-regulated by estrogen(38), suggesting that SMOC1 could be an intermediate between 93 
prenatal sex hormones and digit ratio(29). 94 
 95 
Individuals with Complete Androgen Insensitivity Syndrome (CAIS) exhibit more feminine 2D:4D ratios, 96 
consistent with an effect of reduced prenatal testosterone exposure on digit ratio(39). These 97 
individuals have mutations in the androgen receptor gene (AR), located on the X chromosome, which 98 
codes for a receptor protein that facilitates physiological responses to androgens such as testosterone 99 
and dihydrotestosterone(40).  In vitro studies suggest that the variable number of CAG repeats in exon 100 
1 of AR is inversely related to the efficiency with which the receptor complex binds to DNA and 101 
influences transcription(41). Therefore, an association between the number of CAG repeats at the AR 102 
locus and 2D:4D ratio may indicate that sensitivity to androgens is a major driver of the individual 103 
differences in 2D:4D ratio seen in the normal population(40). 104 
 105 
The aim of the present study was to investigate the genetic determinants of 2D:4D ratio by performing 106 
the largest GWAS meta-analysis (N=15,661, with replication N=75,821) to date. In addition, we aim to 107 
leverage genetics to scrutinize the evidence surrounding the hypothesis that 2D:4D ratio reflects 108 
prenatal androgen exposure. Specifically, we investigated whether there was association between 109 
repeat number in the androgen receptor (XAR) and 2D:4D ratio and we used our GWAS results to 110 
examine: 1) whether there was any association between 2D:4D ratio and genetic variants in pathways 111 
known to be linked with androgens; and 2) whether there was any relationship between 2D:4D ratio 112 
and genetic markers known to be related to (adult) levels of testosterone and/or sex hormone binding 113 
globulin (SHBG). We hypothesize that if 2D:4D ratio is truly influenced by levels of prenatal 114 
testosterone in utero, then it is reasonable to expect that genetic variants related to androgen 115 
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sensitivity (XAR) and/or serum levels of testosterone/SHBG might also show association with 2D:4D 116 
ratio. 117 
 118 
Results: 119 
Study population 120 
Table 1 provides a summary of the studies included in the meta-analysis. Full details of the studies in 121 
the discovery meta-analysis and replication, including how the 2D:4D ratio was measured and the 122 
genotyping methods, are provided in the Supplementary Material. As expected, females had greater 123 
2D:4D ratios than males in all cohorts. The mean and standard deviation of 2D:4D ratios measured on 124 
skeletal images (the Generation R Study and the Rotterdam Study) were lower than those of the other 125 
cohorts measured on photocopies of the hand, consistent with previous reports using this 126 
measure(42). 127 
 128 
Genome-wide complex trait analysis of 2D:4D ratio of the left hand, right hand and mean of both hands 129 
Univariate genetic restricted maximum likelihood (GREML) analysis in ALSPAC revealed that common 130 
genome-wide variation explained a substantial proportion of the variance in 2D:4D ratio (left: 131 
h2SNP=0.299, SE=0.071, P=4.6x10-6; right: h2SNP=0.360, SE=0.071, P=6.2x10-8; mean: h2SNP=0.373, 132 
SE=0.071, P=1.4x10-8). The genetic correlation between the left and right hand ratios was not different 133 
from 1 (rg=0.918, SE=0.074, P=0.14), indicating that the vast majority of SNPs contributing to variation 134 
in the ratio influence both hands. Therefore, in the main text we present the results from the left 135 
(typically non-dominant) hand ratio, due to the larger sample size achieved by including the 136 
Generation R Study, and include the right hand and mean ratio results in the Supplementary Material.  137 
 138 
New genetic loci associated with 2D:4D ratio 139 
The meta-analysis of approximately 8.4 million 1000 genomes-imputed SNPs, including SNPs on the X 140 
chromosome, indicated that the lowest observed P-values for each of the three ratios deviated from 141 
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the expected null distribution (S1-Figure), whereas systematic inflation of the test statistics due to bias 142 
was negligible (λleft=1.020, λright=1.012, λmean=1.014). Further, no evidence of heterogeneity was 143 
detected between the discovery cohorts (S2-Figure). Eleven genomic loci reached genome-wide 144 
significance (P<5x10-8) in the discovery meta-analysis of 15,661 individuals for 2D:4D ratio (Figure 1 145 
for Manhattan plots from the GWAS of the left hand [European only], S3-Figure for the left hand 146 
[multiethnic], right hand and average of both hands). Conditional and joint analysis in the genome-147 
wide complex trait analysis (GCTA) software(43) identified two independent signals in the 16q12.1 148 
locus, totaling 12 independent signals across the three 2D:4D ratio measurements. All 12 signals were 149 
replicated in 75,821 (52.8% male) research participants from 23andMe, Inc. (all P<0.004; Table 2). Of 150 
the nine loci reaching genome-wide significance for the first time, six have not previously been 151 
described in the context of 2D:4D ratio, including: rs11581730 on chromosome 1q22; rs12474669 on 152 
chromosome 2q31.1; rs77640775 on chromosome 7p14.1; rs10790969 on chromosome 11q24.3; 153 
rs6499762 and rs1080014 on chromosome 16q12.1; and rs4799176 on chromosome 18q23. Two of 154 
the nine novel loci were reported at a suggestive significance level (but not genome-wide) in Medland 155 
et al.(30): SNPs in LDAH (previously known as C2orf43) on chromosome 2p24.1 and in GLIS1 on 156 
chromosome 1p32.3. The locus on chromosome 2q31.1 is near the HOXD cluster of genes that are 157 
hypothesized to be required for growth and patterning of the digits, but this is the first time that 158 
convincing evidence for genetic association with 2D:4D ratio has been obtained. The remaining two 159 
loci included SNPs in LIN28B, identified previously by Medland et al.(30) and SMOC1, reported by 160 
Lawrance-Owen et al.(29). A summary of the meta-analysis results for the lead SNPs at each locus that 161 
reached genome-wide significance in the discovery sample are provided in Table 2, with the results 162 
from each study presented in S3-Table and regional plots in S4-Figure. The lead SNPs at the twelve 163 
replicated signals together explain 3.8% of the variance in 2D:4D ratio; this is equivalent to over half 164 
of the variance explained by sex in the Raine Study (5.1%). 165 
 166 
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We conducted analysis of the X chromosome to investigate whether there was evidence for 2D:4D 167 
ratio being partly an X-linked trait. No SNPs on the X chromosome reached genome-wide or suggestive 168 
significance (Figure 1). The HOXA gene cluster, along with the HOXD gene cluster, plays an important 169 
role in limb development, and were initially thought to be essential for the development of the 2D:4D 170 
ratio. Although the HOXD region was associated with 2D:4D ratio in our meta-analysis, there was no 171 
strong evidence for association between variants in the HOXA cluster and 2D:4D ratio (439 SNPs with 172 
all P>0.001, S5-Figure). 173 
 174 
As a secondary analysis, we also conducted sex-stratified analyses in each of the discovery cohorts 175 
and combined the results using a fixed-effects meta-analysis. The majority of the loci reaching 176 
genome-wide significance in the male or female only analyses were identified in the combined analysis 177 
(Miami plots in S6-Figure). One novel locus reached genome-wide significance in the female only 178 
analysis of the left hand 2D:4D ratio in the multi-ethnic meta-analysis. The top SNP in this region, 179 
rs10105686 (C allele [allele frequency = 0.79] Females: β=-0.334, P=2.42x10-9; Males: β=-0.024, 180 
P=0.71), is in FGFR1 on chromosome 8. However, this locus only reached genome-wide significance 181 
for the left hand 2D:4D ratio in the multi-ethnic meta-analysis (P=3.4x10-7 in the female left hand 182 
European analysis), and would not be declared significant after correction for multiple testing given 183 
the large numbers of secondary analyses performed (i.e. secondary analyses involved analysis of 184 
males, females, left hand [both European and multi-ethnic analyses], right hand and average 2D:4D 185 
ratio, plus four sets of genome-wide sex heterogeneity analysis). 186 
 187 
Gene by sex interaction 188 
GREML analysis in ALSPAC showed no significant indication of gene by sex interaction (left: vgxe=0.000, 189 
SE=0.138, P=0.5; right: vgxe=0.117, SE=0.144, P=0.21; mean: vgxe=0.000, SE=0.140, P=0.5). Consistent 190 
with this, only one locus on chromosome 9 reached genome-wide significance for difference in the 191 
magnitude of the regression coefficients between males and females for the average of both hands 192 
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2D:4D ratio (top SNP, rs16929125, A allele frequency = 0.91, heterogeneity P=1.17x10-8; S7-Figure for 193 
Manhattan plots and S8-Figure for QQ plots). However, this locus only reached genome-wide 194 
significance for average 2D:4D ratio, and would not be declared significant after correction for multiple 195 
testing given the large number of secondary analyses performed. 196 
 197 
Gene prioritization, pathway and tissue analysis 198 
We used Data-driven Expression-Prioritized Integration for Complex Traits (DEPICT)(44) to identify the 199 
most likely causal gene at each locus and to investigate enriched pathways. DEPICT identified the 200 
nearest gene to the top associated signal to be the most likely causal gene in 10 of our 12 signals (S4-201 
Table); GLIS1, LDAH (previously known as C2orf43), OLA1, LIN28B, GLI3, FLI1, SMOC1, SALL1, TOX3 and 202 
SALL3. At the 2q31.1 locus, DEPICT prioritized two genes, HODX11 and HOXD12, whilst at the 1q22 203 
locus, five genes were prioritized: EFNA1, DPM3, EFNA3, KRTCAP2 and SLC50A1. We will subsequently 204 
refer to this locus as EFNA1, which is the nearest gene to the top association signal.  205 
 206 
When using the meta-analysis results from the average 2D:4D ratio of both hands, one gene set 207 
reached a false discovery rate (FDR) P<0.01, which mapped to the MSX1 PPI sub-network (S5-Table). 208 
The tissue enrichment analysis did not identify any tissues with a FDR P<0.01 (S6-Table). Based on the 209 
expression data of 53 tissue types from the GTEx Consortium, four of the nearest genes to our lead 210 
SNPs showed high tissue expression in the testis or adrenal gland (LDAH, LIN28B, SMOC1 and 211 
C16orf97; S9-Figure) relative to the other available tissues. Three of these four also showed expression 212 
in the brain (LDAH, LIN28B and SMOC1), in addition to two nearest genes, which showed high 213 
expression in the brain (OLA1 and SALL3). 214 
 215 
Association between 2D:4D ratio and testosterone sensitivity 216 
We examined the association of 2D:4D ratio variation with the length of an established CAG repeat 217 
polymorphism in the AR gene, a proxy of testosterone sensitivity, in a meta-analysis of the ALSPAC 218 
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and QIMR cohorts. We found nominal evidence for a weak positive association between the number 219 
of CAG repeats in the AR gene on the X chromosome and mean 2D:4D ratio in females (mean of 220 
repeats: β=0.056, P=0.02; lower length repeat: β=0.047, P=0.03), but not in males (c.f. Table 3, see S7-221 
Table for left and right 2D:4D ratio).  The 91 SNPs in AR in the GWAS showed little evidence for 222 
association with 2D:4D ratio (minimum P-Value=0.03; S10-Figure). 223 
 224 
2D:4D associated variants and other traits 225 
Given the putative relationship between prenatal testosterone levels and 2D:4D ratio, we also 226 
examined the association between five published SNPs (rs12150660, rs5934505, rs10822186, 227 
rs10822184 and rs72829446) shown to influence testosterone levels(45, 46) using our 2D:4D ratio 228 
meta-analysis of the discovery cohorts; one other reported SNP was not tested, rs6258, as it was 229 
excluded from our meta-analysis as the minor allele frequency was <1%. Due to the high correlation 230 
between testosterone and its principal binding protein, sex hormone-binding globulin (SHBG), we also 231 
tested the association between the 13 published loci for SHBG(47, 48) and 2D:4D ratio. We observed 232 
three associations with left hand 2D:4D ratio at P<0.05: the C allele at rs1641537 (allele frequency = 233 
0.87) was associated with increased 2D:4D ratio (β=0.111, P=0.05) and increased SHBG, the T allele at 234 
rs1573036 (allele frequency = 0.39) was associated with decreased 2D:4D ratio (β=-0.077, P=0.02) and 235 
increased SHBG and the T allele at rs72829446 (allele frequency = 0.11) was associated with increased 236 
2D:4D ratio (β=0.123, P=0.04) and increased testosterone (Figure 2) (i.e. two out of the three 237 
associations were in the opposite direction to expected). We also failed to detect enrichment for 238 
association with 2D:4D ratio over all 18 testosterone and SHBG SNPs (Fisher’s combined probability 239 
test P=0.10). Additionally, there was no difference in the male and female effect sizes from the sex-240 
stratified analyses across the 18 SNPs (Fisher’s combined probability test for the heterogeneity P-value 241 
P=0.23). Only one SNP, rs3779195, showed heterogeneity between males and females with the SHGB 242 
increasing T allele negatively associated with 2D:4D ratio in males and positively associated with 2D:4D 243 
ratio in females (βmale=-0.183, Pmale=0.01; βfemale=0.053, Pfemale=0.39; Phet=0.01). 244 
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Given the previous observational epidemiological associations between 2D:4D ratio and sex-245 
dependent behaviours, we used publicly available GWAS summary results for a variety of traits to 246 
estimate genetic correlations with 2D:4D ratio using linkage-disequilibrium (LD) score regression(49). 247 
We present the genetic correlation results in S8-Table, but advise caution in their interpretation, 248 
considering the recommendation by Bulik-Sullivan et al(49) regarding conducting genetic correlation 249 
analysis for traits with heritability z-scores below 4, as the estimates tend to be noisy and less reliable 250 
(the z-scores for the left hand, right hand and average of both hands were 2.9, 3.0 and 3.3 251 
respectively).  252 
 253 
Discussion: 254 
The 2D:4D ratio, a sexually dimorphic trait, has been extensively used in adults as a biomarker for 255 
prenatal androgen exposure. In the largest genetic association study of 2D:4D ratio to date, we 256 
identified nine novel loci for 2D:4D ratio, in addition to replicating two previously identified loci, 257 
LIN28B and SMOC1. These eleven loci explained 3.8% of the variance in mean 2D:4D ratio. After 258 
assessing association between 2D:4D ratio and a range of testosterone related traits, we found no 259 
conclusive evidence of the 2D:4D ratio constituting a marker of prenatal androgen exposure, although 260 
it is possible that pathways involving testosterone may become apparent as the size of our GWAS 261 
increases in the future. Yet, associations at distinct novel loci provide additional insight into the 262 
underlying biology shaping 2D:4D ratio variation. 263 
 264 
The association signal on 1p32.3 spans GLIS1, which is expressed across several organs in the 265 
reproductive system, including the prostate, vagina, testis and cervix. Glis1, the protein encoded by 266 
GLIS1, is a Kruppel-like zinc finger protein that appears to have a critical role in controlling gene 267 
expression during specific stages of embryogenesis(50).  268 
 269 
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At 1q21-q22, the closest gene to the associated variants is EFNA1, which encodes a member of the 270 
ephrin family and has been implicated in mediating developmental events, notably in the nervous 271 
system. SNPs in the region of EFNA1, DPM3 and KRTCAP3 have previously been associated with 272 
prostate cancer risk(51) and γ-glutamyl transferase (GGT), an indicator of liver disease(52). Based on 273 
the results from GTEx, EFNA1 is also mainly expressed in the liver, which is the most active site of lipid 274 
metabolism. A proxy for our lead 2D:4D ratio associated SNP at this locus, rs11264329, was associated 275 
with total and LDL cholesterol levels(53). Additionally, the top SNP identified at 2p24.1 is in LDAH 276 
(previously known as C2orf43); SNPs in LDAH have also been associated with prostate cancer risk(54, 277 
55). The protein encoded by LDAH is involved in cholesterol mobilization(56). Testosterone, which is 278 
linked to prostate cancer risk, is created when luteinizing hormone (LH) triggers the testicular Leydig 279 
cells to convert cholesterol to testosterone. Therefore, these two loci could implicate cholesterol 280 
metabolism in steroidogenesis as a link to testosterone exerting a role on 2D:4D ratio variation, albeit 281 
requiring further investigation into the functional implications.  282 
 283 
OLA1, which maps to the 2q31.1 locus, plays multiple roles in the regulation of cell proliferation and 284 
cell survival. Ding et al. show that mouse embryos lacking OLA1 have delayed development leading to 285 
immature organs and stunted growth, which were frequently lethal prenatally(57). Their data suggests 286 
that there is a defect in cell proliferation due to a delay in cell cycle progression meaning that the 287 
mutant embryos appeared to undergo fewer proliferation cycles resulting in growth restriction.   288 
 289 
SNPs in the 7p14.1 region map within GLI3. The gene encodes a zinc finger transcription factor that 290 
functions in the hedgehog signal transduction pathway. SNPs in this region have also been associated 291 
with facial morphology, namely nose wing breadth(58), and implicated in several Mendelian disorders 292 
which are characterized by craniofacial and limb abnormalities. Specifically, there are several 293 
disorders and conditions where polydactyly is a feature(59), including Greig cephalopolysyndactyly 294 
syndrome (GCPS), and Pallister-Hall syndrome (PHS). There is some evidence for brachydactyly 295 
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(shortened digits) in a mouse null Gli3 mutant developed by Sheth et al.(60), and in patients with 296 
PHS(59).  297 
 298 
The association signal arising from the 11q24.1-q24.3 locus is intergenic between FLI1 and ETS1. 299 
Through GWAS, SNPs in the FLI1 gene have been shown to be associated with height, with similar 300 
effects in both males and females(61). In addition, SNPs in ETS1 have been shown to be associated 301 
with rheumatoid arthritis(62) and celiac disease(63) in European populations and with systemic lupus 302 
erythematosus(64-66) in Chinese populations; all of these diseases have a higher prevalence in 303 
females. This gene encodes the protein Ets1, which is expressed in a variety of tissues throughout the 304 
development of an embryo and plays a role in pituitary hormone secretion(67).  In mice, the ETS factor 305 
family defines Shh spatial expression in limb buds and alterations define pathogenetic mechanism 306 
leading to preaxial polydactyly(68). 307 
 308 
The GWAS signal on chromosome 16q12.1 maps in the vicinity of the SALL1, TOX3 and C16orf97 genes. 309 
Not much is known about the function of C16orf97. However, SALL1 was identified by DEPICT as being 310 
the most likely causal gene for the rs6499762 association; mutations in SALL1 cause Townes-Brocks 311 
syndrome(69), a condition characterized by hand malformations, abnormally shaped ears and anal 312 
atresia, among other genital malformations(70). Additionally, SALL3 on chromosome 18q23, is also 313 
part of the human spalt-like gene family, which is associated with syndromic forms presenting with 314 
skeletal abnormalities. Kohlhase et al.(71) characterized this gene and implicated it in the 18q deletion 315 
syndrome, which results in mental and growth retardation, developmental delay, hearing loss, and 316 
facial and limb abnormalities including tapered fingers(72). Altogether, several links between 2D:4D 317 
ratio and testosterone metabolism can be derived from these associations, involving hormonal 318 
pathways and the process of sexual differentiation during early development. Further, SNPs in the 319 
SALL3 region have also been associated with prostate cancer(51), which may suggest additional links 320 
between 2D:4D ratio and testosterone.   321 
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One gene set was identified as being associated with 2D:4D ratio, the MSX1 PPI subnetwork. An Msx1-322 
interacting network of transcription factors has been shown to operate during early tooth 323 
development(73). Therefore, the identification of this gene set may be highlighting a network that is 324 
involved in several areas of development. 325 
 326 
Interestingly, we didn’t find strong evidence of association between variants within the HOXA gene 327 
cluster and 2D:4D ratio. This lack of association does not preclude variation in distal enhancers acting 328 
through effects on the expression of HOXA cluster genes nor that variants of smaller effect acting from 329 
within the cluster itself (with an alpha of 5x10-8 we had 80% power to detect a genetic variant that 330 
explained approximately 0.28% of the variance in the left hand 2D:4D ratio in Europeans only 331 
(N=14,382)). We did, however, find an association involving a variant in HOXD12 (the most strongly 332 
associated SNP was rs847158, P=9.58x10-11, which replicated in the 23andMe dataset). The exact role 333 
of HOXD12 has not yet been determined; however, the homeobox family of genes plays an important 334 
role in morphogenesis and is particularly relevant in the development of the limbs and genitals(74). 335 
 336 
2D:4D as a marker of testosterone exposure 337 
2D:4D ratio has been used extensively in adults as a biomarker for prenatal androgen exposure. 338 
However, whether the digit ratio reliably reflects prenatal androgen exposure has not been 339 
convincingly demonstrated. Most of the data linking 2D:4D ratio with prenatal androgen exposure is 340 
based on preclinical or indirect evidence, including studies that indicate that 2D:4D ratio is fixed early 341 
in gestation and is associated with adult levels of circulating testosterone(3, 75). The most direct test 342 
of this hypothesis to date was performed by Lutchmaya et al. who showed that testosterone levels in 343 
amniotic fluid from the second trimester of pregnancy were not associated with 2D:4D ratio at two 344 
years of age(76). However, the authors did find that an increased ratio of testosterone to estradiol 345 
was associated with a lower (or more male like) 2D:4D ratio, suggesting that the relationship between 346 
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digit ratio and prenatal hormones may be more complicated and not only reflect testosterone 347 
levels(76, 77). 348 
 349 
In the present study we attempted to use genetic evidence to find support for the testosterone 350 
biomarker hypothesis. Our rationale was that if prenatal testosterone affects 2D:4D ratio, then it is 351 
logical that polymorphisms in genes related to androgen sensitivity (e.g. in XAR) and/or SNPs robustly 352 
associated with androgen levels/levels of SHBG, should also be related to 2D:4D ratio. Whilst we did 353 
detect some evidence of a positive association between the number of CAG repeats in AR and 2D:4D 354 
ratio in females, we note that the small effect size would not be significant after adjusting for the 355 
multiple statistical tests we performed. Power calculations suggest that our combined sample of 356 
N=5,826 individuals in the XAR meta-analysis was well powered (~78%) to detect a locus responsible 357 
for 0.001% of the phenotypic variance in 2D:4D ratio (one tailed α=0.05). In comparison, all of our 358 
genome-wide significant SNPs explained >0.001% of the variance in 2D:4D ratio (most explained much 359 
more variance than this). This suggests that if genetic variation in XAR does contribute to variation in 360 
2D:4D ratio through, for example, sensitivity to testosterone, its effect is likely to be small relative to 361 
other sources of genetic variation. Two recent smaller meta-analyses also failed to find an association 362 
between length of the repeat in XAR and 2D:4D ratio(78, 79). 363 
 364 
Likewise, using SNPs that are associated with testosterone and SHBG we were unable to detect any 365 
enrichment for association with 2D:4D ratio. We were also unable to identify any genetic correlation 366 
between 2D:4D ratio and a range of traits and diseases previously implicated with 2D:4D ratio 367 
variation. This indicates that the previously identified observational associations may not be driven by 368 
known genetic loci that are shared between the traits, although we acknowledge the power of analysis 369 
was low and confidence intervals around our estimates were large.  370 
 371 
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Whilst we were unable to find any convincing evidence that sensitivity to/levels of androgens is a 372 
major driver of the individual differences in 2D:4D ratio seen in the normal population, there are 373 
several key assumptions underlying the use of genetic variation to investigate the link between 374 
prenatal androgen exposure and 2D:4D ratio. First, investigating the association between the number 375 
of CAG repeats in AR and 2D:4D ratio relies on the assumption that CAG length reflects androgen 376 
sensitivity. There is fairly good evidence for this, at least in vitro as derived from the Chamberlain et 377 
al. functional study showing a linear relationship between increased CAG length and decreased 378 
transactivation function(41). Secondly, we assume that the genotyping of the CAG repeat is accurate. 379 
Although there was some discordance in the replicate genotyping in ALSPAC, the majority of 380 
discrepancies were only one CAG repeat different between the replicates. Our simulations presented 381 
in the Supplementary Material indicate that this degree of measurement error had little influence on 382 
the power of our association analysis. Thirdly, we assume that the SNPs associated with adult levels 383 
of testosterone/SHBG also reflect testosterone/SHBG levels prenatally and that the effect of these 384 
SNPs are similar in males and females. The testosterone associated SNPs were identified in GWAS of 385 
adult men only and one of the two GWAS for SHBG, identifying only one novel locus, was in post-386 
menopausal women only. However, Coviello et al. conducted sex-stratified analyses and identified 387 
only one locus with significant heterogeneity on SHBG between males and females (48). They also 388 
showed that the SHBG SNPs identified explained ~15.6% of the variation in SHBG in men and ~8.4% of 389 
the variation in women. This indicates that although the SNPs have a greater overall effect in males, 390 
they are still likely to be associated with androgens in females. It is too difficult to measure androgen 391 
levels in the fetus so we are unable to confirm that these SNPs are also associated with androgen 392 
levels prenatally. Finally, although none of our novel loci showed direct evidence of being related to 393 
pathways involving testosterone, it does not preclude the very real possibility that testosterone 394 
influences 2D:4D ratio by downregulating or upregulating the expression of genes involved in its 395 
determination. Indeed, in GWAS of height (80)and BMI (81)the role of expected hormone pathways 396 
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only appeared when the studies were sufficiently powered to find far greater number of genome-wide 397 
significant hits than in the present study. 398 
 399 
In conclusion, we have conducted the largest GWAS of 2D:4D ratio to date and identified nine novel 400 
loci robustly associated with 2D:4D ratio in Europeans, bringing the total number of robustly 401 
associated loci to eleven. We were unable to find strong evidence from our genetic study to support 402 
the hypothesis that 2D:4D ratio is a direct biomarker of prenatal exposure to androgens in healthy 403 
individuals, although our findings do not explicitly exclude this possibility, and pathways involving 404 
testosterone may become apparent as the size of the discovery sample increases further. Our findings 405 
provide new insight into the underlying biology shaping 2D:4D variation in the general population. 406 
  407 
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Materials and Methods: 408 
Participants  409 
We drew on data from six cohorts for the discovery genome-wide meta-analysis and association with 410 
the CAG repeat in AR including the Avon Longitudinal Study of Parents and Children (ALSPAC), the 411 
Generation R Study, the Rotterdam Study, the Western Australian Pregnancy Cohort (Raine) Study, 412 
TwinsUK and the Queensland Institute of Medical Research (QIMR) sample, which was drawn from 413 
the Brisbane Adolescent Twin Study (BATS; also known as the Brisbane Longitudinal Twin Study 414 
(BLTS)). The 23andMe cohort was used for replication of the genome-wide significant findings. Details 415 
of each of these studies, including how the 2D:4D ratio was measured and the genotyping methods, 416 
are provided in the Supplementary Material.  417 
 418 
Ethics Statement 419 
All cohorts in the discovery meta-analysis or replication obtained ethical approval from their local 420 
ethics review boards; ALSAPC from the ALSPAC Law and Ethics Committee and the Local Research 421 
Ethics Committees, The Generation R Study from the Medical Ethics Committee of the Erasmus 422 
Medical Center in Rotterdam, QIMR from the QIMR Human Research Ethics Committee, the Raine 423 
study from the King Edward Memorial Hospital and Princess Margaret Hospital for Children Human 424 
Research Ethics Committees, the Rotterdam Study from the Medical Ethics Committee of the Erasmus 425 
Medical Center in Rotterdam, TwinsUK from the Guy’s and St Thomas’ (GSTT) Ethics Committee and 426 
research participants from 23andMe provided informed consent and participated in the research 427 
online, under a protocol approved by the external AAHRPP-accredited IRB, Ethical & Independent 428 
Review Services (E&I Review).  429 
  430 
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Statistical Analysis 431 
The 2D:4D ratio was calculated as the length of the second digit divided by the length of the fourth 432 
digit, multiplied by 100 so as to avoid computational difficulties due to the low variance of the trait. 433 
In all studies, the measure was normally distributed, so no further transformation was applied. 434 
 435 
Genome-wide complex trait analysis of 2D:4D ratio: 436 
To estimate the proportion of additive genetic variance in 2D:4D ratio explained by directly genotyped 437 
SNPs we conducted a univariate genetic restricted maximum likelihood (GREML) analysis using the 438 
genome-wide complex trait analysis (GCTA) software(82) in >4,900 individuals from ALSPAC. Sex was 439 
included as a fixed effect in the model. Bivariate GREML analysis(83) was used to estimate the genetic 440 
correlation between the left and right hand 2D:4D ratio, which will indicate whether the same genetic 441 
variants contribute to variation in the ratio of each hand. Additionally, a gene by sex analysis was 442 
conducted using the gene by environment test, to indicate whether the SNPs associated with 2D:4D 443 
ratio differed between males and females. 444 
 445 
Genome-wide association analysis - Discovery: 446 
Genome-wide association analysis using imputed dosages to account for uncertainty in the imputation 447 
was performed using linear regression in each cohort, adjusting for sex. In addition, the QIMR and 448 
TwinsUK cohorts accounted for zygosity and relatedness. The Generation R Study (European subset), 449 
the Rotterdam Study and Raine adjusted for four principal components for population stratification. 450 
A sensitivity analysis to maximize power was conducted by including all individuals of the Generation 451 
R Study with adjustment for 20 principal components to account for the multi-ethnic sample as 452 
performed earlier(84-88). Results presented in the main text are derived from the meta-analysis 453 
including the European subset only, with the multi-ethnic analysis presented in the Supplementary 454 
Material. SNPs were tested for association with left 2D:4D ratio, right 2D:4D ratio (all cohorts excluding 455 
the Generation R Study) and the mean of the left and right hand 2D:4D ratios (all cohorts excluding 456 
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the Generation R Study). Results were combined using fixed-effects inverse-variance weighted meta-457 
analysis in METAL(89), adjusting for genomic control. Within each study, SNPs with a MAF < 1%, an 458 
INFO score < 0.4 or R2 for imputation quality < 0.3 were excluded from the meta-analysis and SNPs 459 
that were reported in less than 50% of the total sample size were excluded from further follow-up. 460 
 461 
We also tested whether the regression coefficients differed between males and females. We carried 462 
out genome-wide association analysis in males and females separately in each of the discovery cohorts 463 
and, as with the main analysis, we excluded variants with a MAF <1% and poor imputation quality 464 
(INFO score <0.4 or R2 for imputation quality < 0.3). We performed a fixed-effects inverse-variance 465 
weighted meta-analysis of each sex in METAL(89), adjusting for genomic control. Finally, we excluded 466 
variants that were reported less than 50% of the male and female sample sizes, and performed a chi-467 
square test of heterogeneity between the meta-analyzed male and female effects in METAL(89) to 468 
test for the difference between the effect sizes in males and females and produce an overall level of 469 
significance.   470 
 471 
Conditional and joint association analysis: 472 
We performed approximate conditional and joint SNP association analysis using the GCTA 473 
software(43), which utilizes meta-analysis summary statistics and linkage disequilibrium (LD) structure 474 
from a reference sample. We used this approach to identify additional signals in regions of association, 475 
using a subset of 15,000 UK Biobank(90) individuals as the reference sample to approximate LD 476 
patterns. The selected subset of the UK Biobank individuals were of European descent and unrelated 477 
to anyone else in the subset. 478 
 479 
Genome-wide association analysis - Replication: 480 
SNPs that reached genome-wide significance (P<5x10-8 for the left, right or average 2D:4D ratio) in the 481 
discovery meta-analysis were replicated in the 23andMe dataset. If the imputed SNP passed quality 482 
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control or the genotyped SNP was unavailable, then the imputed SNP was used for analysis, otherwise 483 
the genotyped SNP was used. Analysis of each SNP was performed using linear regression, adjusting 484 
for sex, age, the first five principal components for population stratification and genotyping platform. 485 
Results were adjusted for a genomic control inflation factor of λ=1.074. 486 
 487 
Variance explained:  488 
The variance explained by each SNP was calculated using the effect size from the discovery meta-489 
analysis (beta, β), the minor and major allele frequencies (p and q respectively) and the variance of 490 
the 2D:4D ratio (Var(Y)) using the following formula:  491 
𝑉𝑎𝑟𝐸𝑥𝑝 = 2𝑝𝑞 
𝛽2
𝑉𝑎𝑟(𝑌)
 492 
We used the median standard deviation in 2D:4D ratio across the cohorts, which was 3.40 for the left 493 
hand, 3.35 for the right hand and 3.06 for the average of both hands to calculate the phenotypic 494 
variance in this formula. Under the assumption that all SNPs independently contribute to 2D:4D ratio, 495 
we computed the total variance explained by the lead SNPs at the genome-wide significant loci as the 496 
sum of the single-SNP explained variances. 497 
 498 
Gene prioritization, gene set and tissue/cell type enrichment analysis: 499 
We conducted three analyses implemented in DEPICT (44) to establish the functional connections with 500 
our lead signals. First, we prioritized genes which are most likely to be causal for 2D:4D ratio by 501 
correlating the reconstituted gene set membership of each gene nearby the associated signal to genes 502 
from other associated loci and adjusting for potential sources of bias such as gene size. Second, we 503 
performed a gene set enrichment analysis, which tests if the genes in the associated loci are enriched 504 
in the reconstituted gene-sets. Third, we analysed expression enrichment across particular tissues or 505 
cell types, by testing whether genes associated with 2D:4D ratio loci were seen highly expressed in 506 
any of the 209 Medical Subject Heading (MeSH) annotations using data from 37,427 expression arrays. 507 
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In all three analyses, we used false discovery rate (FDR) to adjust for multiple testing, with an FDR P-508 
value < 0.01 defined as significant. 509 
 510 
The DEPICT analyses were based on independent lead SNPs (r2<0.1, European populations 1000 511 
genomes reference panel) with P-values below the genome-wide significant threshold (P < 5x10-8). 512 
Gene-set enrichment was further grouped into ‘meta gene sets’ by similarity clustering, as previously 513 
described (44). 514 
 515 
Additionally, we investigated the functionality of the genes closest to the lead SNPs identified in these 516 
analyses using expression data on 53 tissue types from the Genotype-Tissue Expression (GTEx) 517 
consortium(91) 518 
 519 
Analysis of the CAG repeat polymorphism in AR: 520 
Information on the CAG repeat polymorphism in AR was available in the ALSPAC and QIMR cohorts 521 
(see Supplementary Material for genotyping information). In ALSPAC, we performed linear regression 522 
of 2D:4D ratio (left, right and mean of the left and right) on length of CAG repeat (in females either 523 
average repeat length, the highest length repeat or the lower length repeat). The QIMR analyses were 524 
conducted using full information maximum likelihood structural equation models in openMx(92) 525 
which explicitly accounted for relatedness and zygosity while estimating the linear effect of the CAG 526 
repeat on 2D:4D ratio. We performed analyses including all participants (with sex as a covariate), 527 
females separately and males separately. A fixed-effects inverse-variance weighted meta-analysis was 528 
used to combine the results from the two cohorts using the rmeta package in R (version 3.0.0)(93). A 529 
one-tailed hypothesis was used to test whether there was a positive association between the number 530 
of CAG repeats and 2D:4D ratio. 531 
 532 
 533 
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Genetic correlation with associated traits:  534 
We used LD score regression, which has been described in detail elsewhere(49), to calculate the 535 
genetic correlation between 2D:4D ratio and a range of traits and diseases it has been associated with 536 
in observational studies. Note, we conducted this analysis using the European only meta-analysis 537 
results as LD score regression cannot accommodate LD variation between diverse populations. Briefly, 538 
the LD Score is a measure of how much genetic variation each SNP tags; so if a SNP has a high LD Score 539 
then it is in high LD with many nearby SNPs. SNPs with high LD Scores are more likely to contain more 540 
true signals and hence provide more chance for overlap with genuine signals between GWAS. The 541 
method uses summary statistics from the GWAS meta-analyses of 2D:4D ratio and the traits of 542 
interest, calculates the cross-product of test statistics at each SNP, and then regresses the cross-543 
product on the LD Score. The slope of the regression is a function of the genetic correlation between 544 
traits. If there is overlap between the samples used in each of the meta-analyses (or cryptic 545 
relatedness between samples) it will only affect the intercept of the regression, and will not bias the 546 
estimate of the genetic covariance.  547 
 548 
Summary statistics from the GWAS meta-analysis for traits and diseases of interest were downloaded 549 
from the relevant consortium website (see S8-Table for references). The summary statistics files were 550 
reformatted for LD Score regression analysis using the munge_sumstats.py python script provided on 551 
the developer’s website (https://github.com/bulik/ldsc); we filtered the summary statistics to the 552 
subset of HapMap3 SNPs, as advised by the developers, to ensure that no bias was introduced due to 553 
poor imputation quality. Where the sample size for each SNP was included in the results file this was 554 
flagged using --N-col; if no sample size was available then the maximum sample size reported in the 555 
reference for the GWAS meta-analysis was used (i.e the summary statistics for each SNP was assumed 556 
to have been estimated using the same sample size). SNPs were excluded if the minor allele frequency 557 
was <0.01, the strand was ambiguous, the rs number was duplicated or they had a sample size less 558 
than 60% of the total sample size available. Once all the files were reformatted, we used the ldsc.py 559 
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python script, also on the developer’s website, to calculate the genetic correlation between 2D:4D 560 
ratio and each of the traits and diseases. The European LD Score files that were calculated from the 561 
1000 Genomes reference panel and provided by the developers were used for the analysis.  562 
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Figure Legends: 942 
Figure 1: Manhattan plot from the discovery meta-analysis of left hand 2D:4D ratio. The red line 943 
indicates genome-wide significance (P<5x10-8) and the yellow line indicates suggestive significance 944 
(P<1x10-5). Purple dots indicate those loci that reach genome-wide significance. 945 
 946 
Figure 2: Plots highlighting the relationship of 13 SHBG and five testosterone associated SNPs (45-48) 947 
with the left hand 2D:4D ratio discovery meta-analysis. (A) Q-Q plot of the meta-analysis P-values for 948 
each of the SNPs. (B) Plot of the β coefficient for the left hand 2D:4D ratio meta-analysis against the β 949 
coefficient previously reported for SHBG or testosterone (the 13 SHBG associated SNPs are aligned to 950 
the SHBG increasing allele and the five testosterone associated SNPs are aligned to the testosterone 951 
increasing allele). Triangles indicate SNPs associated with testosterone, circles indicate SNPs 952 
associated with SHBG.  953 
  954 
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Table 1: Descriptive statistics of the discovery and replication cohorts. 955 
Variable Subset ALSPAC Generation R QIMR Raine Rotterdam Study Twins UK 
N All 5,337 3,059 2,775 1,003 2,091 1,396 
Age (years)a All 11.74 (0.23) 9.80 (0.33) 15.47 (2.93) 20.05 (0.43) 67.84 (7.91) 54.84 (12.21) 
Sex (male)b All 49% (2615) 47.9% (1465) 46.4% (1287) 50.85% (510) 42.9% (897) 9.10% (127) 
Left 2D:4Da All 96.53 (3.25) 91.15 (2.72) 97.66 (3.41) 96.52 (3.45) 92.40 (2.24) 96.70 (3.40) 
Male 96.05 (3.17) 90.74 (2.77) 96.87 (3.38) 96.16 (3.33) 91.96 (2.25) 95.25 (3.24) 
Female 97.00 (3.26) 91.52 (2.62) 98.33 (3.29) 96.93 (3.53) 92.73 (2.17) 96.80 (3.42) 
Right 2D:4Da All 96.37 (3.28) -- 97.07 (3.43) 96.99 (3.28) 92.39 (2.42) 97.10 (3.50) 
Male 95.87 (3.22) -- 96.12 (3.29) 96.81 (3.28) 91.94 (2.39) 95.58 (3.38) 
Female 96.87 (3.26) -- 97.88 (3.33) 97.19 (3.28) 92.73 (2.39) 97.24 (3.48) 
Mean 2D:4Da All 96.45 (2.99) -- 97.39 (3.10) 96.76 (3.04) 92.40 (2.12) 96.90 (3.10) 
Male 95.96 (2.90) -- 96.51 (3.01) 96.48 (2.94) 91.95 (2.13) 95.42 (2.99) 
Female 96.93 (3.00) -- 98.14 (2.97) 97.06 (3.12) 92.71 (2.05) 97.02 (3.07) 
a Mean (SD); b Percent (number) 956 
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Table 2: Genome-wide-significant loci from the discovery meta-analysis in all individuals for left hand 957 
2D:4D ratio; the most significant SNP from each locus is presented. Replication results are presented 958 
from 23andMe where the 2D:4D ratio was reported as a relative measure (i.e. 0 = index finger longer 959 
[17.1% of research participants], 1 = index and ring finger the same length [14.0% of research 960 
participants], 2 = ring finger longer [68.9% of research participants]). 961 
 Chr Position 
(bp 
[GRCh37/ 
hg19]) 
Nearest gene Effect 
allele 
/ 
Other 
allele 
EAFa Beta SE P-Value 
rs4927012 
Discovery 1 54068016 GLIS1 T/C  0.875 -0.358 0.058 5.08x10-10 
Replication 1 54068016 GLIS1 T/C 0.871 -0.042 0.006 3.48x10-12 
rs11581730 
Discovery 1 155082158 EFNA1 A/T 0.496 0.294 0.036 3.02x10-16 
Replication 1 155082158 EFNA1 A/T 0.503 0.026 0.004 4.99x10-11 
rs340600 
Discovery 2 20892006 LDAHb T/G 0.199 -0.379 0.046 1.38x10-16 
Replication 2 20892006 LDAHb T/G 0.199 -0.043 0.005 1.81x10-17 
rs12474669 
Discovery 2 175134232 OLA1 A/G 0.139 0.417 0.054 1.51x10-14 
Replication 2 175134232 OLA1 A/G 0.143 0.043 0.006 1.92x10-13 
rs847158 
Discovery 2 176962102 HOXD12/HOXD11 A/G 0.602 0.199 0.037 1.03x10-7 
Replication 2 176962102 HOXD12/HOXD11 A/G 0.609 0.039 0.004 3.04x10-20 
rs314277c 
Discovery 6 105407662 LIN28B A/C 0.155 0.428 0.050 5.55x10-18 
Replication 6 105407662 LIN28B A/C 0.149 0.067 0.006 1.77x10-32 
rs77640775d 
Discovery 7 42190714 GLI3 A/G 0.137 -0.252 0.053 1.92x10-6 
Replication 7 42190714 GLI3 A/G 0.146 -0.033 0.006 6.64x10-9 
rs10790969 
Discovery 11 128529842 FLI1 T/C 0.276 0.284 0.040 1.33x10-12 
Replication 11 128529842 FLI1 T/C 0.272 0.027 0.005 1.26x10-9 
rs2332175c 
Discovery 14 70345411 SMOC1 A/G 0.529 0.360 0.037 3.00x10-22 
Replication 14 70345411 SMOC1 A/G 0.546 0.045 0.004 6.74x10-29 
rs6499762 
Discovery 16 51697874 SALL1 A/C 0.125 0.441 0.056 5.33x10-15 
Replication 16 51697874 SALL1 A/C 0.129 0.083 0.006 2.83x10-41 
rs1080014 
Discovery 16 51900171 TOX3 C/T 0.514 0.203 0.036 1.94x10-8 
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 Chr Position 
(bp 
[GRCh37/ 
hg19]) 
Nearest gene Effect 
allele 
/ 
Other 
allele 
EAFa Beta SE P-Value 
Replication 16 51900171 TOX3 C/T 0.501 0.012 0.004 3.35x10-3 
rs4799176 
Discovery 18 76378307 SALL3 C/T 0.256 0.305 0.044 4.09x10-12 
Replication 18 76378307 SALL3 C/T 0.244 0.057 0.005 1.89x10-34 
a Average effect allele frequency (EAF) across the cohorts in each of the meta-analyses. 962 
b Previously known as C2orf43. 963 
c Genetic loci that had previously been associated with 2D:4D ratio in Medland et al. 2010. 964 
d SNP passed genome-wide significance in the average 2D:4D ratio meta-analysis (see supplementary material 965 
for results) 966 
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Table 3: Association between the number of CAG repeats in the AR gene and the mean of the left 968 
and right hand 2D:4D ratios. Displayed are beta (SE) and P-values in each of the cohorts and the 969 
combined estimates from the fixed effects, inverse-variance weighted meta-analysis. ‘Mean’ refers 970 
to analyses involving the average CAG repeat length, ‘High’ refers to analyses involving the highest 971 
length repeat and ‘Low’ refers to analyses involving the lower length repeat. One-tailed P-values 972 
testing for a positive association between CAG repeat length and 2D:4D ratio are presented. 973 
 ALSPAC  QIMR  Meta-Analysis 
All Individuals 
 N=5328 N=498 N=5826 
Mean 0.014 (0.016), P=0.19 0.040 (0.052), P=0.22 0.016 (0.015), P=0.14 
High 0.012 (0.015), P=0.21 0.014 (0.046), P=0.38 0.012 (0.014), P=0.20 
Low 0.013 (0.016), P=0.21 0.041 (0.057), P=0.24 0.015 (0.015), P=0.16 
Male 
 N=2615 N=231 N=2846 
Mean -0.002 (0.020), P=0.54 -0.099 (0.083), P=0.88 -0.007 (0.019), P=0.65 
Female 
 N=2713 N=287 N=3000 
Mean 0.046 (0.028), P=0.05 0.125 (0.072), P=0.04 0.056 (0.026), P=0.02 
High 0.030 (0.025), P=0.12 0.068 (0.058), P=0.12 0.036 (0.023), P=0.06 
Low 0.040 (0.026), P=0.06 0.112 (0.082), P=0.09 0.047 (0.025), P=0.03 
 974 
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Supplementary Information Captions: 975 
Supplementary information includes: 976 
 977 
S1-Figure: QQ Plots from the discovery GWAS meta-analysis for left hand (European only; A), left 978 
hand (Multiethnic; B), right hand (C) and mean (D) 2D:4D ratio. 979 
 980 
S2-Figure: QQ Plots of the heterogeneity P-value from the discovery meta-analysis for the left hand 981 
(European only; A), left hand (Multi-ethnic; B), right hand (C) and mean (D) 2D:4D ratio. 982 
 983 
S3-Figure: Manhattan plots from the discovery meta-analysis for the left hand (multiethnic; A), right 984 
hand (B) and average of both hands (C) 2D:4D ratios. The red line indicates genome-wide significance 985 
(P<5x10-8) and the yellow line indicates suggestive significance (P<1x10-5). Purple dots indicate those 986 
loci that reach genome-wide significance. 987 
 988 
S4-Figure: Regional association plot for each of the loci reaching genome-wide significance with the 989 
top SNP highlighted in purple. 990 
 991 
S5-Figure: Region plots from the discovery meta-analysis of the HOXA gene cluster and 200kb either 992 
side of the gene cluster, for the left hand (European; A), left hand (Multiethnic; B) right hand (C) and 993 
mean (D) 2D:4D ratio. The SNP with the lowest P-value in the region for each of the three phenotypes 994 
is highlighted in purple. 995 
 996 
S6-Figure: Miami plots from the sex-stratified analyses, with females on the upper axis and males on 997 
the lower, for the left hand (European; A), left hand (Multiethnic; B), right hand (C) and average of 998 
both hands (D) 2D:4D ratios. The red line indicates genome-wide significance (P<5x10-8) and the yellow 999 
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line indicates suggestive significance (P<1x10-5). Purple dots indicate those loci that reach genome-1000 
wide significance. 1001 
 1002 
S7-Figure: Manhattan plots from the heterogeneity test between male and female effect sizes for the 1003 
left hand (European; A), left hand (Multiethnic; B), right hand (C) and average of both hands (D) 2D:4D 1004 
ratios. The red line indicates genome-wide significance (P<5x10-8) and the yellow line indicates 1005 
suggestive significance (P<1x10-5). Purple dots indicate those loci that reach genome-wide 1006 
significance. 1007 
 1008 
S8-Figure: QQ Plots from the heterogeneity test between male and female effect sizes for left hand 1009 
(European only; A), left hand (Multiethnic; B), right hand (C) and mean (D) 2D:4D ratio. 1010 
 1011 
S9-Figure: Gene expression profiles of the nearest gene to the lead SNPs using data from the GTEx 1012 
Consortium. The y-axis shows the Reads Per Kilobase of transcript per Million mapped reads (PRKM). 1013 
 1014 
S10-Figure: Region plots from the discovery meta-analysis of the AR gene, and 200kb either side of 1015 
the gene, for the left hand (European; A), left hand (Multiethnic; B) right hand (C) and mean (D) 1016 
2D:4D ratio. The SNP with the lowest P-value in the region for each of the three phenotypes is 1017 
highlighted in purple. 1018 
 1019 
S1-Table: Reliability of the CAG(n) polymorphism in the ALSPAC cohort across genotyping replicates 1020 
in the subset of individuals used for quality control (N=370). 1021 
 1022 
S2-Table: Power, bias and coverage probability results from the simulations mimicking the ALSPAC 1023 
data where the number of CAG repeats was simulated without and with measurement error. 1024 
 1025 
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S3-Table: Genome-wide-significant loci from the discovery meta-analysis in all individuals; the most 1026 
significant SNP from each locus is presented.  1027 
 1028 
S4-Table: Most likely causal gene at each locus identified by DEPICT 1029 
 1030 
S5-Table: Results from the geneset enrichment analysis in DEPICT 1031 
 1032 
S6-Table: Results from the tissue enrichment analysis in DEPICT 1033 
 1034 
S7-Table: Results for the regression of 2D:4D ratio (left and right hand) on number of CAG repeats in 1035 
the AR gene. Each cell displays the beta coefficient (SE) and P-value from the regression. Results are 1036 
presented for each of the cohorts and the combined estimates from the fixed effects, inverse-1037 
variance weighted meta-analysis. ‘Mean’ is the average repeat length, ‘High’ the highest length 1038 
repeat and ‘Low’ is the lower length repeat. 1039 
 1040 
S8-Table: Genome-wide SNP-heritability and genetic correlation between 2D:4D ratio and a range of 1041 
traits and diseases.  1042 
 1043 
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